• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Intravenous Thrombolysis in Acute Ischemic Stroke Patients Pretreated With Non-Vitamin K Antagonist Oral Anticoagulants: An Editorial Review.

作者信息

Tsivgoulis Georgios, Safouris Apostolos

机构信息

From the Second Department of Neurology, National and Kapodistrian University of Athens, School of Medicine, "Attikon" University Hospital, Greece (G.T., A.S.); Department of Neurology, University of Tennessee Health Science Center, Memphis (G.T.); and Acute Stroke Unit, Metropolitan Hospital, Piraeus, Greece (A.S.).

出版信息

Stroke. 2017 Jul;48(7):2031-2033. doi: 10.1161/STROKEAHA.117.017206. Epub 2017 May 23.

DOI:10.1161/STROKEAHA.117.017206
PMID:28536167
Abstract
摘要

相似文献

1
Intravenous Thrombolysis in Acute Ischemic Stroke Patients Pretreated With Non-Vitamin K Antagonist Oral Anticoagulants: An Editorial Review.非维生素K拮抗剂口服抗凝剂预处理的急性缺血性卒中患者的静脉溶栓治疗:一篇社论综述
Stroke. 2017 Jul;48(7):2031-2033. doi: 10.1161/STROKEAHA.117.017206. Epub 2017 May 23.
2
Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome.急性缺血性脑卒中患者的再通治疗:新型口服抗凝剂治疗对出血并发症和结局的影响。
Circulation. 2015 Sep 29;132(13):1261-9. doi: 10.1161/CIRCULATIONAHA.115.015484. Epub 2015 Jul 31.
3
Prime Time for a Trial Assessing Safety of Intravenous Thrombolysis in Patients Treated With Direct Oral Anticoagulants.评估直接口服抗凝剂治疗患者静脉溶栓安全性试验的黄金时机。
Stroke. 2024 Jun;55(6):e149-e150. doi: 10.1161/STROKEAHA.123.046142. Epub 2024 Apr 26.
4
Treatment of acute ischemic stroke: recent progress.急性缺血性卒中的治疗:近期进展
Intern Med. 2002 May;41(5):337-44. doi: 10.2169/internalmedicine.41.337.
5
Intravenous thrombolysis for acute ischaemic stroke in the setting of rivaroxaban use.在使用利伐沙班的情况下对急性缺血性卒中进行静脉溶栓治疗。
J Clin Neurosci. 2014 Nov;21(11):2013-5. doi: 10.1016/j.jocn.2014.03.029. Epub 2014 Jun 28.
6
Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.心房颤动卒中后抗凝治疗的三个月风险效益概况:SAMURAI-非瓣膜性心房颤动(NVAF)研究
Int J Stroke. 2016 Jul;11(5):565-74. doi: 10.1177/1747493016632239. Epub 2016 Feb 29.
7
Treatment of acute ischaemic stroke with thrombolysis or thrombectomy in patients receiving anti-thrombotic treatment.接受抗血栓治疗的患者进行溶栓或取栓治疗急性缺血性脑卒中。
Lancet Neurol. 2013 Jul;12(7):677-88. doi: 10.1016/S1474-4422(13)70101-7. Epub 2013 May 31.
8
Intravenous thrombolysis in acute ischemic stroke: standard and potential future applications.急性缺血性卒中的静脉溶栓治疗:标准及未来潜在应用
Expert Rev Neurother. 2014 Aug;14(8):879-92. doi: 10.1586/14737175.2014.934676. Epub 2014 Jul 2.
9
[Systemic thrombolysis after the administration of idarucizumab in acute ischemic stroke].[急性缺血性卒中患者接受艾达司珠单抗治疗后进行全身溶栓]
Ideggyogy Sz. 2017 Jul 30;70(7-8):284-288. doi: 10.18071/isz.70.0284.
10
Safety of Endovascular Thrombectomy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants.接受非维生素K拮抗剂口服抗凝剂治疗的患者行血管内血栓切除术的安全性
Stroke. 2016 Apr;47(4):1127-30. doi: 10.1161/STROKEAHA.116.012684. Epub 2016 Mar 1.

引用本文的文献

1
Point-of-Care Assessment of Direct Oral Anticoagulation in Acute Ischemic Stroke: Protocol for a Prospective Observational Diagnostic Accuracy Study.即时检测在急性缺血性脑卒中直接口服抗凝治疗中的应用:一项前瞻性观察性诊断准确性研究方案。
Thromb Haemost. 2022 Nov;122(11):1954-1962. doi: 10.1055/a-1869-7853. Epub 2022 Jun 7.
2
Effect of Apixaban Pretreatment on Alteplase-Induced Thrombolysis: An Study.阿哌沙班预处理对阿替普酶诱导溶栓的影响:一项研究。
Front Pharmacol. 2021 Sep 15;12:740930. doi: 10.3389/fphar.2021.740930. eCollection 2021.
3
European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke.
欧洲卒中组织(ESO)急性缺血性卒中静脉溶栓指南。
Eur Stroke J. 2021 Mar;6(1):I-LXII. doi: 10.1177/2396987321989865. Epub 2021 Feb 19.
4
Recanalisation therapies for acute ischaemic stroke in patients on direct oral anticoagulants.直接口服抗凝剂治疗的急性缺血性脑卒中患者的再通治疗。
J Neurol Neurosurg Psychiatry. 2021 May;92(5):534-541. doi: 10.1136/jnnp-2020-325456. Epub 2021 Feb 4.
5
Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation.缺血性脑卒中合并心房颤动患者的抗凝治疗前评估。
Ann Neurol. 2021 Jan;89(1):42-53. doi: 10.1002/ana.25917. Epub 2020 Oct 17.
6
Patients on NOACs in the Emergency Room.在急诊室使用 NOAC 的患者。
Curr Neurol Neurosci Rep. 2019 May 29;19(7):40. doi: 10.1007/s11910-019-0954-7.
7
Clinical presentation, diagnostic findings and management of cerebral ischemic events in patients on treatment with non-vitamin K antagonist oral anticoagulants - A systematic review.非维生素 K 拮抗剂口服抗凝剂治疗患者的脑缺血事件的临床表现、诊断结果和处理 - 系统评价。
PLoS One. 2019 Mar 29;14(3):e0213379. doi: 10.1371/journal.pone.0213379. eCollection 2019.
8
Intravenous tPA (Tissue-Type Plasminogen Activator) in Patients With Acute Ischemic Stroke Taking Non-Vitamin K Antagonist Oral Anticoagulants Preceding Stroke.急性缺血性脑卒中患者在卒中前服用非维生素 K 拮抗剂口服抗凝剂时的静脉注射 tPA(组织型纤溶酶原激活物)。
Stroke. 2018 Sep;49(9):2237-2240. doi: 10.1161/STROKEAHA.118.022128.